Dynatronics Corporation (DYNT)
USD 0.11
(1.92%)
USD 0.11
(1.92%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 3.25 Million USD | -100.0% |
| 2023 | 4.28 Million USD | 60.79% |
| 2022 | 2.66 Million USD | -31.14% |
| 2021 | 3.87 Million USD | -54.98% |
| 2020 | 8.59 Million USD | 182.43% |
| 2019 | 3.04 Million USD | -7.06% |
| 2018 | 3.27 Million USD | -7.71% |
| 2017 | 3.54 Million USD | -7.44% |
| 2016 | 3.83 Million USD | -6.83% |
| 2015 | 4.11 Million USD | 227.93% |
| 2014 | 1.25 Million USD | -19.63% |
| 2013 | 1.56 Million USD | -18.5% |
| 2012 | 1.91 Million USD | -14.39% |
| 2011 | 2.23 Million USD | -14.06% |
| 2010 | 2.6 Million USD | -9.61% |
| 2009 | 2.88 Million USD | -5.4% |
| 2008 | 3.04 Million USD | -6.32% |
| 2007 | 3.25 Million USD | 60.7% |
| 2006 | 2.02 Million USD | 52.1% |
| 2005 | 1.33 Million USD | -14.38% |
| 2004 | 1.55 Million USD | -11.42% |
| 2003 | 1.75 Million USD | -10.06% |
| 2002 | 1.95 Million USD | 6.29% |
| 2001 | 1.83 Million USD | -11.52% |
| 2000 | 2.07 Million USD | -13.59% |
| 1999 | 2.4 Million USD | -14.29% |
| 1998 | 2.8 Million USD | 33.33% |
| 1997 | 2.1 Million USD | -16.0% |
| 1996 | 2.5 Million USD | 19.05% |
| 1995 | 2.1 Million USD | -4.55% |
| 1994 | 2.2 Million USD | 100.0% |
| 1993 | 1.1 Million USD | 1000.0% |
| 1992 | 100 Thousand USD | 0.0% |
| 1991 | - USD | 0.0% |
| 1990 | - USD | 0.0% |
| 1989 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q4 | 3.25 Million USD | -100.0% |
| 2024 Q1 | 3.95 Million USD | 0.0% |
| 2024 Q3 | 3.47 Million USD | -5.87% |
| 2024 Q2 | 3.69 Million USD | -6.63% |
| 2023 FY | 4.28 Million USD | 60.79% |
| 2023 Q1 | 2.45 Million USD | -7.82% |
| 2023 Q4 | 4.28 Million USD | -7.17% |
| 2023 Q3 | 4.61 Million USD | 10.02% |
| 2023 Q2 | 4.19 Million USD | 70.79% |
| 2022 Q1 | 3.54 Million USD | -8.32% |
| 2022 Q3 | 2.87 Million USD | -9.92% |
| 2022 Q2 | 3.19 Million USD | -10.07% |
| 2022 FY | 2.66 Million USD | -31.14% |
| 2022 Q4 | 2.66 Million USD | -7.29% |
| 2021 Q2 | 6.24 Million USD | -20.57% |
| 2021 FY | 3.87 Million USD | -54.98% |
| 2021 Q1 | 7.85 Million USD | -8.64% |
| 2021 Q3 | 4.62 Million USD | -25.85% |
| 2021 Q4 | 3.87 Million USD | -16.33% |
| 2020 Q2 | 5.2 Million USD | -6.27% |
| 2020 Q1 | 5.55 Million USD | 82.34% |
| 2020 Q3 | 4.84 Million USD | -6.9% |
| 2020 Q4 | 8.59 Million USD | 77.5% |
| 2020 FY | 8.59 Million USD | 182.43% |
| 2019 Q3 | 3.16 Million USD | 2.84% |
| 2019 Q4 | 3.04 Million USD | -3.69% |
| 2019 FY | 3.04 Million USD | -7.06% |
| 2019 Q1 | 3.17 Million USD | -3.05% |
| 2019 Q2 | 3.07 Million USD | -3.21% |
| 2018 Q4 | 3.27 Million USD | -0.14% |
| 2018 FY | 3.27 Million USD | -7.71% |
| 2018 Q1 | 3.46 Million USD | -2.52% |
| 2018 Q3 | 3.28 Million USD | -2.75% |
| 2018 Q2 | 3.37 Million USD | -2.51% |
| 2017 Q4 | 3.54 Million USD | -2.33% |
| 2017 FY | 3.54 Million USD | -7.44% |
| 2017 Q1 | 3.74 Million USD | -2.46% |
| 2017 Q2 | 3.65 Million USD | -2.21% |
| 2017 Q3 | 3.63 Million USD | -0.65% |
| 2016 Q4 | 3.83 Million USD | -2.09% |
| 2016 FY | 3.83 Million USD | -6.83% |
| 2016 Q3 | 3.91 Million USD | -1.14% |
| 2016 Q2 | 3.96 Million USD | -1.92% |
| 2016 Q1 | 4.03 Million USD | -1.86% |
| 2015 Q3 | 4.22 Million USD | -1.47% |
| 2015 Q1 | 4.38 Million USD | 249.62% |
| 2015 Q2 | 4.28 Million USD | -2.28% |
| 2015 FY | 4.11 Million USD | 227.93% |
| 2015 Q4 | 4.11 Million USD | -2.58% |
| 2014 Q1 | 1.47 Million USD | -5.27% |
| 2014 Q4 | 1.25 Million USD | -5.61% |
| 2014 Q2 | 1.4 Million USD | -5.13% |
| 2014 Q3 | 1.32 Million USD | -5.26% |
| 2014 FY | 1.25 Million USD | -19.63% |
| 2013 Q2 | 1.69 Million USD | -6.38% |
| 2013 Q4 | 1.56 Million USD | -4.91% |
| 2013 Q3 | 1.64 Million USD | -3.31% |
| 2013 FY | 1.56 Million USD | -18.5% |
| 2013 Q1 | 1.81 Million USD | -5.32% |
| 2012 Q1 | 2.16 Million USD | -3.29% |
| 2012 Q3 | 2.01 Million USD | -3.89% |
| 2012 FY | 1.91 Million USD | -14.39% |
| 2012 Q4 | 1.91 Million USD | -4.98% |
| 2012 Q2 | 2.09 Million USD | -3.07% |
| 2011 FY | 2.23 Million USD | -14.06% |
| 2011 Q4 | 2.23 Million USD | -3.91% |
| 2011 Q3 | 2.32 Million USD | -3.82% |
| 2011 Q2 | 2.42 Million USD | -3.62% |
| 2011 Q1 | 2.51 Million USD | -3.52% |
| 2010 Q1 | 2.79 Million USD | -2.99% |
| 2010 FY | 2.6 Million USD | -9.61% |
| 2010 Q4 | 2.6 Million USD | -4.02% |
| 2010 Q3 | 2.71 Million USD | 0.05% |
| 2010 Q2 | 2.71 Million USD | -2.97% |
| 2009 FY | 2.88 Million USD | -5.4% |
| 2009 Q1 | 3 Million USD | -1.23% |
| 2009 Q4 | 2.88 Million USD | 0.91% |
| 2009 Q2 | 2.92 Million USD | -2.73% |
| 2009 Q3 | 2.85 Million USD | -2.41% |
| 2008 Q2 | 3.17 Million USD | -2.01% |
| 2008 Q3 | 3.11 Million USD | -2.08% |
| 2008 FY | 3.04 Million USD | -6.32% |
| 2008 Q4 | 3.04 Million USD | -2.06% |
| 2008 Q1 | 3.24 Million USD | -0.31% |
| 2007 Q1 | 1.96 Million USD | -2.73% |
| 2007 FY | 3.25 Million USD | 60.7% |
| 2007 Q4 | 3.25 Million USD | 75.35% |
| 2007 Q3 | 1.85 Million USD | -2.98% |
| 2007 Q2 | 1.91 Million USD | -2.9% |
| 2006 FY | 2.02 Million USD | 52.1% |
| 2006 Q1 | 1.27 Million USD | -4.23% |
| 2006 Q2 | 2.15 Million USD | 68.78% |
| 2006 Q3 | 2.08 Million USD | -3.02% |
| 2006 Q4 | 2.02 Million USD | -2.97% |
| 2005 Q4 | 1.33 Million USD | -4.93% |
| 2005 FY | 1.33 Million USD | -14.38% |
| 2005 Q1 | 1.5 Million USD | -3.4% |
| 2005 Q2 | 1.44 Million USD | -3.43% |
| 2005 Q3 | 1.39 Million USD | -3.46% |
| 2004 Q3 | 1.6 Million USD | -3.11% |
| 2004 Q2 | 1.65 Million USD | -3.1% |
| 2004 Q1 | 1.7 Million USD | -2.77% |
| 2004 Q4 | 1.55 Million USD | -2.95% |
| 2004 FY | 1.55 Million USD | -11.42% |
| 2003 FY | 1.75 Million USD | -10.06% |
| 2003 Q1 | 1.89 Million USD | -2.78% |
| 2003 Q3 | 1.81 Million USD | -2.33% |
| 2003 Q2 | 1.85 Million USD | -1.93% |
| 2003 Q4 | 1.75 Million USD | -3.42% |
| 2002 Q2 | 1.75 Million USD | -1.31% |
| 2002 FY | 1.95 Million USD | 6.29% |
| 2002 Q4 | 1.95 Million USD | 14.54% |
| 2002 Q3 | 1.7 Million USD | -2.96% |
| 2002 Q1 | 1.77 Million USD | -3.1% |
| 2001 Q3 | 1.89 Million USD | -3.14% |
| 2001 FY | 1.83 Million USD | -11.52% |
| 2001 Q1 | 2.01 Million USD | -2.83% |
| 2001 Q2 | 1.95 Million USD | -2.98% |
| 2001 Q4 | 1.83 Million USD | -3.1% |
| 2000 FY | 2.07 Million USD | -13.59% |
| 2000 Q2 | 2.2 Million USD | -4.35% |
| 2000 Q3 | 2.12 Million USD | -3.33% |
| 2000 Q4 | 2.07 Million USD | -2.48% |
| 2000 Q1 | 2.3 Million USD | -4.17% |
| 1999 Q1 | 2.8 Million USD | 0.0% |
| 1999 Q3 | 2.3 Million USD | 0.0% |
| 1999 Q4 | 2.4 Million USD | 4.35% |
| 1999 Q2 | 2.3 Million USD | -17.86% |
| 1999 FY | 2.4 Million USD | -14.29% |
| 1998 Q2 | 2 Million USD | 0.0% |
| 1998 Q3 | 2.2 Million USD | 10.0% |
| 1998 Q4 | 2.8 Million USD | 27.27% |
| 1998 FY | 2.8 Million USD | 33.33% |
| 1998 Q1 | 2 Million USD | -4.76% |
| 1997 Q2 | 2.4 Million USD | -4.0% |
| 1997 Q4 | 2.1 Million USD | 0.0% |
| 1997 FY | 2.1 Million USD | -16.0% |
| 1997 Q1 | 2.5 Million USD | 0.0% |
| 1997 Q3 | 2.1 Million USD | -12.5% |
| 1996 Q3 | 2 Million USD | 0.0% |
| 1996 FY | 2.5 Million USD | 19.05% |
| 1996 Q1 | 2.1 Million USD | 0.0% |
| 1996 Q2 | 2 Million USD | -4.76% |
| 1996 Q4 | 2.5 Million USD | 25.0% |
| 1995 Q1 | 2.2 Million USD | 0.0% |
| 1995 FY | 2.1 Million USD | -4.55% |
| 1995 Q4 | 2.1 Million USD | 0.0% |
| 1995 Q3 | 2.1 Million USD | -4.55% |
| 1995 Q2 | 2.2 Million USD | 0.0% |
| 1994 Q3 | 2.4 Million USD | 4.35% |
| 1994 Q1 | 1.9 Million USD | 72.73% |
| 1994 Q2 | 2.3 Million USD | 21.05% |
| 1994 Q4 | 2.2 Million USD | -8.33% |
| 1994 FY | 2.2 Million USD | 100.0% |
| 1993 FY | 1.1 Million USD | 1000.0% |
| 1993 Q3 | 700 Thousand USD | 133.33% |
| 1993 Q1 | 100 Thousand USD | 0.0% |
| 1993 Q2 | 300 Thousand USD | 200.0% |
| 1993 Q4 | 1.1 Million USD | 57.14% |
| 1992 Q4 | 100 Thousand USD | 0.0% |
| 1992 Q2 | - USD | 0.0% |
| 1992 FY | 100 Thousand USD | 0.0% |
| 1992 Q1 | - USD | 0.0% |
| 1992 Q3 | 100 Thousand USD | 0.0% |
| 1991 FY | - USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 Q1 | - USD | 0.0% |
| 1991 Q3 | - USD | 0.0% |
| 1991 Q4 | - USD | 0.0% |
| 1990 Q3 | - USD | 0.0% |
| 1990 FY | - USD | 0.0% |
| 1990 Q4 | - USD | 0.0% |
| 1989 Q4 | - USD | 0.0% |
| 1989 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 36.1 Million USD | 90.974% |
| BrainsWay Ltd. | 239 Thousand USD | -1263.38% |
| Cerus Corporation | 59.79 Million USD | 94.551% |
| Envoy Medical, Inc. | 404 Thousand USD | -706.554% |
| electroCore, Inc. | 537 Thousand USD | -506.793% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -27053.983% |
| IceCure Medical Ltd | 376 Thousand USD | -766.616% |
| Inogen, Inc. | 18.27 Million USD | 82.165% |
| OrthoPediatrics Corp. | 13.45 Million USD | 75.79% |
| Lucid Diagnostics Inc. | 199 Thousand USD | -1537.426% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -795.866% |
| MaxCyte, Inc. | 17.96 Million USD | 81.866% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -5794.071% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| Orthofix Medical Inc. | 93.1 Million USD | 96.5% |
| PAVmed Inc | 2.96 Million USD | -10.084% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | 47.562% |
| RxSight, Inc. | 1.21 Million USD | -169.073% |
| Sight Sciences, Inc. | 31.7 Million USD | 89.723% |
| SI-BONE, Inc. | 36.06 Million USD | 90.965% |
| TELA Bio, Inc. | 40.51 Million USD | 91.957% |
| Treace Medical Concepts, Inc. | 53 Million USD | 93.853% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | -114.233% |
| Acutus Medical, Inc. | 32.65 Million USD | 90.021% |
| Talis Biomedical Corporation | 16.78 Million USD | 80.588% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | 19.444% |
| CVRx, Inc. | 30.38 Million USD | 89.275% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 1.01 Million USD | -220.423% |
| Bioventus Inc. | 366.99 Million USD | 99.112% |
| Venus Concept Inc. | 70.79 Million USD | 95.397% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | -161.936% |
| LivaNova PLC | 568.54 Million USD | 99.427% |
| 908 Devices Inc. | 3.92 Million USD | 17.066% |
| Alphatec Holdings, Inc. | 511.03 Million USD | 99.362% |
| Nemaura Medical Inc. | 3.08 Million USD | -5.533% |
| NeuroPace, Inc. | 56.95 Million USD | 94.279% |
| LENSAR, Inc. | 1.75 Million USD | -86.199% |
| Apyx Medical Corporation | 33.18 Million USD | 90.181% |
| Cutera, Inc. | 418.69 Million USD | 99.222% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | 78.34% |
| BioSig Technologies, Inc. | 103 Thousand USD | -3063.571% |
| Anika Therapeutics, Inc. | 26.9 Million USD | 87.888% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | 67.248% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 99.781% |
| Axonics, Inc. | 25.84 Million USD | 87.39% |
| Outset Medical, Inc. | 134.59 Million USD | 97.579% |
| IRIDEX Corporation | 1.75 Million USD | -86.092% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | 93.653% |
| IRadimed Corporation | 1.61 Million USD | -101.753% |
| Tivic Health Systems, Inc. | 176 Thousand USD | -1751.408% |
| INVO Bioscience, Inc. | 6.77 Million USD | 51.912% |
| Telesis Bio, Inc. | 5.26 Million USD | 38.158% |
| Viemed Healthcare, Inc. | 5.97 Million USD | 45.431% |
| Varex Imaging Corporation | 464.2 Million USD | 99.298% |
| Quipt Home Medical Corp. | 60.82 Million USD | 94.643% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -454.163% |
| Pulmonx Corporation | 35.08 Million USD | 90.714% |
| Modular Medical, Inc. | 817 Thousand USD | -298.835% |
| ReShape Lifesciences Inc. | 151 Thousand USD | -2057.932% |
| Semler Scientific, Inc. | 70 Thousand USD | -4554.969% |
| InMode Ltd. | 6.61 Million USD | 50.726% |
| Bruker Corporation | 1.14 Billion USD | 99.715% |
| Cytosorbents Corporation | 2.54 Million USD | -28.142% |
| DexCom, Inc. | 2.57 Billion USD | 99.873% |
| Align Technology, Inc. | 96.96 Million USD | 96.64% |
| Viveve Medical, Inc. | 5.12 Million USD | 36.408% |
| ZimVie Inc. | 508.79 Million USD | 99.36% |
| Movano Inc. | 15.00 USD | -21723086.667% |
| Cytek Biosciences, Inc. | 18.12 Million USD | 82.022% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | 99.183% |
| Profound Medical Corp. | 4.97 Million USD | 34.495% |
| Insulet Corporation | 1.36 Billion USD | 99.762% |
| enVVeno Medical Corporation | 1.06 Million USD | -206.248% |
| Surmodics, Inc. | 29.4 Million USD | 88.919% |
| iCAD, Inc. | 273 Thousand USD | -1093.582% |
| Nuwellis, Inc. | 221 Thousand USD | -1374.424% |
| Biotricity, Inc. | 10.85 Million USD | 69.984% |
| iRhythm Technologies, Inc. | 34.95 Million USD | 90.677% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | -401.496% |
| InspireMD, Inc. | 1.03 Million USD | -213.919% |
| PAVmed Inc. | 2.96 Million USD | -10.084% |
| BIOLASE, Inc. | 13.98 Million USD | 76.7% |
| Beyond Air, Inc. | 14.72 Million USD | 77.865% |
| FONAR Corporation | 37.92 Million USD | 91.409% |
| AxoGen, Inc. | 46.6 Million USD | 93.008% |
| Vivani Medical, Inc. | 19.31 Million USD | 83.128% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | 92.696% |
| Inari Medical, Inc. | 30.35 Million USD | 89.265% |
| UFP Technologies, Inc. | 28 Million USD | 88.363% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | -650.724% |
| Tenon Medical, Inc. | 428 Thousand USD | -661.327% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -225.197% |
| Co-Diagnostics, Inc. | 2.15 Million USD | -51.404% |
| AdaptHealth Corp. | 2.09 Billion USD | 99.844% |
| Sintx Technologies, Inc. | 3.68 Million USD | 11.623% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | 91.246% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -454.163% |
| Sensus Healthcare, Inc. | 596 Thousand USD | -446.724% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 99.635% |
| TransMedics Group, Inc. | 506.2 Million USD | 99.356% |
| ReWalk Robotics Ltd. | 607 Thousand USD | -436.817% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -3423.25% |
| Hyperfine, Inc. | 64 Thousand USD | -4991.372% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | 98.274% |
| Biomerica, Inc. | 459 Thousand USD | -609.908% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -624.939% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -1615.106% |
| Silk Road Medical, Inc | 75.62 Million USD | 95.691% |